In this episode, Anthony and Bernie discuss the AML abstracts at ASH that we found most intriguing and controversial!
Abstracts:

FILO - Stopping Aza/Ven: https://ash.confex.com/ash/2023/webprogram/Paper185437.html
Revumenib Late Breaking Abstract:
https://ash.confex.com/ash/2023/webprogram/Paper192042.html
JNJ617 Menin Inhibitor Data:
https://ash.confex.com/ash/2023/webprogram/Paper172422.html
SAVE Trial (Revumenib + PO Dec/ven):
https://ash.confex.com/ash/2023/webprogram/Paper182337.html
Dec/Ven vs. 3+7 Randomized Phase II:
https://ash.confex.com/ash/2023/webprogram/Paper181347.html
NCRI AML18 RCT:
https://ash.confex.com/ash/2023/webprogram/Paper185956.html
Impact of NPM1+/FLT3+/MRD in AML17 and AML19:
https://ash.confex.com/ash/2023/webprogram/Paper179033.html
CBF and NPM1 MRD:
https://ash.confex.com/ash/2023/webprogram/Paper184848.html
Persistent MRD by PCR but Flow Negativity in CBF AML (Mast Cell Madness):
https://ash.confex.com/ash/2023/webprogram/Paper180275.html
MORPHO More MRD Analysis:
https://ash.confex.com/ash/2023/webprogram/Paper177929.html